Abiopharma

Arctic Fox Lithium Corp. is a Canadian junior mineral exploration company focused on the acquisition, exploration and development of lithium, copper and other critical mineral properties in Canada. The Company is primarily engaged in advancing a portfolio of exploration-stage assets located in Québec and British Columbia, with an emphasis on hard rock lithium and copper porphyry opportunities. Arctic Fox’s core projects include the Kana Lake Lithium Project, Pontax North Lithium Project, Delta Lake Lithium Project and the Spius Copper Property. The Company’s strategy is centered on identifying and advancing prospective mineral assets in mining-friendly jurisdictions that support the growing global demand for battery metals and electrification-related resources. Arctic Fox is listed on the Canadian Securities Exchange under the symbol “AFX” and on the Frankfurt Stock Exchange under the symbol “O5K”.

Additional info from OTC:
Arctic Fox Lithium Corp. is a Canadian junior mineral exploration company focused on the acquisition, exploration and development of lithium, copper and other critical mineral properties in Canada. The Company is primarily engaged in advancing a portfolio of exploration-stage assets located in Québec and British Columbia, with an emphasis on hard rock lithium and copper porphyry opportunities. Arctic Fox’s core projects include the Kana Lake Lithium Project, Pontax North Lithium Project, Delta Lake Lithium Project and the Spius Copper Property. The Company’s strategy is centered on identifying and advancing prospective mineral assets in mining-friendly jurisdictions that support the growing global demand for battery metals and electrification-related resources. Arctic Fox is listed on the Canadian Securities Exchange under the symbol “AFX” and on the Frankfurt Stock Exchange under the symbol “O5K”.